878130C

C16-18:1 PE

Avanti Research^™ - A Croda Brand 878130C

• Synonym(e): 1-hexadecyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphoethanolamine
• Empirische Formel (Hill-System): C₃₉H₇₈NO₇P
• CAS-Nummer: 119904-40-4
• Molekulargewicht: 704.01
• UNSPSC-Code: 12352211
• NACRES: NA.25

Eigenschaften

• Form: liquid
• Verpackung: pkg of 1 × 1 mL (878130C-5mg)
• Hersteller/Markenname: Avanti Research^™ - A Croda Brand 878130C
• Konzentration: 5 mg/mL (878130C-5mg)
• Lipid-Typ: bioactive lipids; phosphoglycerides
• Versandbedingung: dry ice
• Lagertemp.: −20°C
• SMILES String: [H][C@@](COP([O-])(OCC[NH3+])=O)(OC(CCCCCCC/C=C\CCCCCCCC)=O)COCCCCCCCCCCCCCCCC

Beschreibung

Anwendung

C16-18:1 PE or 1-hexadecyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphoethanolamine has been used as a lipid standard in liquid chromatography with tandem mass spectrometry (LC-MS-MS) and LC-20AD prominence high performance liquid chromatography system to quantify glycerophosphoethanolamines.

Verpackung

5 mL Clear Glass Sealed Ampule (878130C-5mg)

Rechtliche Hinweise

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Sicherheitshinweise

• Piktogramme: GHS06,GHS08
• Signalwort: Danger
• H-Sätze: H302,H315,H319,H331,H336,H351,H361d,H372
• P-Sätze: P201 - P301 + P312 - P302 + P352 - P304 + P340 + P311 - P305 + P351 + P338 - P308 + P313
• Gefahreneinstufungen: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 Oral - STOT SE 3
• Zielorgane: Central nervous system, Liver,Kidney
• Lagerklassenschlüssel: 6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects
• WGK: WGK 3
• Flammpunkt (°F): does not flash
• Flammpunkt (°C): does not flash